A preclinical-stage biopharmaceutical company developing first-in-class, shelf-stable wound healing therapeutics — making advanced care accessible everywhere.

Product

Zegen-X5

The Science

Pipeline

Company

Impact

Market

Partnerships

Contact us

Connect

manushsm@zegenex.com

Investor Relations

Blog

© 2026 ZegeneX. All rights reserved.

For accredited investor / qualified institutional buyer use only.